These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Glucuronidation of the aspirin metabolite salicylic acid by expressed UDP-glucuronosyltransferases and human liver microsomes. Kuehl GE; Bigler J; Potter JD; Lampe JW Drug Metab Dispos; 2006 Feb; 34(2):199-202. PubMed ID: 16258079 [TBL] [Abstract][Full Text] [Related]
3. UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: I. Identification of polymorphisms in the 5'-regulatory and exon 1 regions, and association with human liver UGT1A6 gene expression and glucuronidation. Krishnaswamy S; Hao Q; Al-Rohaimi A; Hesse LM; von Moltke LL; Greenblatt DJ; Court MH J Pharmacol Exp Ther; 2005 Jun; 313(3):1331-9. PubMed ID: 15761114 [TBL] [Abstract][Full Text] [Related]
4. UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: II. Functional impact of the three most common nonsynonymous UGT1A6 polymorphisms (S7A, T181A, and R184S). Krishnaswamy S; Hao Q; Al-Rohaimi A; Hesse LM; von Moltke LL; Greenblatt DJ; Court MH J Pharmacol Exp Ther; 2005 Jun; 313(3):1340-6. PubMed ID: 15761113 [TBL] [Abstract][Full Text] [Related]
5. Effect of genetic polymorphisms in UDP-glucuronosyltransferase 1A6 (UGT1A6) on acetylsalicylic acid metabolism in healthy female volunteers. van Oijen MG; Barthélémy C; Janssen MJ; Joiris E; Peters WH; Laheij RJ; Smits P; Odou P; Jansen JB Pharmacology; 2009; 83(4):237-42. PubMed ID: 19262071 [TBL] [Abstract][Full Text] [Related]
6. Determinants of aspirin metabolism in healthy men and women: effects of dietary inducers of UDP-glucuronosyltransferases. Navarro SL; Saracino MR; Makar KW; Thomas SS; Li L; Zheng Y; Levy L; Schwarz Y; Bigler J; Potter JD; Lampe JW J Nutrigenet Nutrigenomics; 2011; 4(2):110-8. PubMed ID: 21625173 [TBL] [Abstract][Full Text] [Related]
7. UDP-glucuronosyltransferase (UGT1A1*28 and UGT1A6*2) polymorphisms in Caucasians and Asians: relationships to serum bilirubin concentrations. Lampe JW; Bigler J; Horner NK; Potter JD Pharmacogenetics; 1999 Jun; 9(3):341-9. PubMed ID: 10471066 [TBL] [Abstract][Full Text] [Related]
8. Characterizing the effects of common UDP glucuronosyltransferase (UGT) 1A6 and UGT1A1 polymorphisms on cis- and trans-resveratrol glucuronidation. Iwuchukwu OF; Ajetunmobi J; Ung D; Nagar S Drug Metab Dispos; 2009 Aug; 37(8):1726-32. PubMed ID: 19406951 [TBL] [Abstract][Full Text] [Related]
9. UGT1A6 and UGT2B15 polymorphisms and acetaminophen conjugation in response to a randomized, controlled diet of select fruits and vegetables. Navarro SL; Chen Y; Li L; Li SS; Chang JL; Schwarz Y; King IB; Potter JD; Bigler J; Lampe JW Drug Metab Dispos; 2011 Sep; 39(9):1650-7. PubMed ID: 21666065 [TBL] [Abstract][Full Text] [Related]
10. The metabolism of aspirin in man: a population study. Hutt AJ; Caldwell J; Smith RL Xenobiotica; 1986 Mar; 16(3):239-49. PubMed ID: 3705620 [TBL] [Abstract][Full Text] [Related]
11. Quantitative determination of five metabolites of aspirin by UHPLC-MS/MS coupled with enzymatic reaction and its application to evaluate the effects of aspirin dosage on the metabolic profile. Li JP; Guo JM; Shang EX; Zhu ZH; Liu Y; Zhao BC; Zhao J; Tang ZS; Duan JA J Pharm Biomed Anal; 2017 May; 138():109-117. PubMed ID: 28192718 [TBL] [Abstract][Full Text] [Related]
12. Deferiprone glucuronidation by human tissues and recombinant UDP glucuronosyltransferase 1A6: an in vitro investigation of genetic and splice variants. Benoit-Biancamano MO; Connelly J; Villeneuve L; Caron P; Guillemette C Drug Metab Dispos; 2009 Feb; 37(2):322-9. PubMed ID: 18971318 [TBL] [Abstract][Full Text] [Related]
13. In vitro glucuronidation of thyroxine and triiodothyronine by liver microsomes and recombinant human UDP-glucuronosyltransferases. Tong Z; Li H; Goljer I; McConnell O; Chandrasekaran A Drug Metab Dispos; 2007 Dec; 35(12):2203-10. PubMed ID: 17875670 [TBL] [Abstract][Full Text] [Related]
15. Interactions between CYP2C9 and UGT1A6 polymorphisms and nonsteroidal anti-inflammatory drugs in colorectal cancer prevention. Samowitz WS; Wolff RK; Curtin K; Sweeney C; Ma KN; Andersen K; Levin TR; Slattery ML Clin Gastroenterol Hepatol; 2006 Jul; 4(7):894-901. PubMed ID: 16797247 [TBL] [Abstract][Full Text] [Related]
16. Comparative metabolism of high doses of aspirin in man and rat. Patel DK; Notarianni LJ; Bennett PN Xenobiotica; 1990 Aug; 20(8):847-54. PubMed ID: 2219967 [TBL] [Abstract][Full Text] [Related]
17. The influence of UGT1A6 variants and aspirin use in a randomized trial of celecoxib for prevention of colorectal adenoma. Chan AT; Hsu M; Zauber AG; Hawk ET; Bertagnolli MM Cancer Prev Res (Phila); 2012 Jan; 5(1):61-72. PubMed ID: 22030088 [TBL] [Abstract][Full Text] [Related]
18. Urinary excretion of phenytoin metabolites, 5-(4'-hydroxyphenyl)-5-phenylhydantoin and its O-glucuronide in humans and analysis of genetic polymorphisms of UDP-glucuronosyltransferases. Yamanaka H; Nakajima M; Hara Y; Katoh M; Tachibana O; Yamashita J; Yokoi T Drug Metab Pharmacokinet; 2005 Apr; 20(2):135-43. PubMed ID: 15855726 [TBL] [Abstract][Full Text] [Related]
19. Tissue-specific patterns of gene expression in the epithelium and stroma of normal colon in healthy individuals in an aspirin intervention trial. Thomas SS; Makar KW; Li L; Zheng Y; Yang P; Levy L; Rudolph RY; Lampe PD; Yan M; Markowitz SD; Bigler J; Lampe JW; Potter JD BMC Med Genet; 2015 Mar; 16():18. PubMed ID: 25927723 [TBL] [Abstract][Full Text] [Related]
20. Genetic variants in the UGT1A6 enzyme, aspirin use, and the risk of colorectal adenoma. Chan AT; Tranah GJ; Giovannucci EL; Hunter DJ; Fuchs CS J Natl Cancer Inst; 2005 Mar; 97(6):457-60. PubMed ID: 15770010 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]